Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BYBioactive Materials

Cyborg bacteria as semi-living organelles for the augmentation of mammalian cells

  1. 1Department of Biomedical Engineering, University of California, Davis, CA, USA
  2. 2Department of Animal Science, University of California, Davis, CA, USA
  3. 3Department of Biomedical Engineering, University of California, Davis, CA, USA; Corresponding author.

Abstract

Synthetic organelles are engineered to replicate the compartmentalization and dynamic functionality of natural organelles, offering the potential to reprogram or rescue cellular functions. Existing approaches, such as protein cages, biomolecular condensates, and other artificial compartments, have shown promise but remain limited by their capacity to perform multifunctional tasks. To overcome these challenges, we introduce Cyborg Bacterial Organelles (CBOs), which are non-replicating, metabolically active bacteria engineered to function as living synthetic organelles within mammalian cells. Unlike synthetic systems or replicating endosymbionts, CBOs integrate the biological complexity of living organisms with the stability and tunability of engineered materials. CBOs are generated by permeating bacteria with poly(ethylene glycol) diacrylate (PEG) based monomers followed by intracellular UV induced hydrogel crosslinking, producing a structurally reinforced, non-replicative chassis capable of sustained activity inside host cells. Here, we show that CBOs remained detectable inside mammalian cells with substantially reduced morphological disruption compared with wild-type bacteria. Furthermore, we show that CBOs can perform complex functions intracellularly, including responses to extracellular chemical stimuli via synthetic gene circuits and execution of enzymatic reactions such as prodrug conversion into a therapeutic drug. Notably, we also show that CBOs protect host cells from chemically induced mitochondrial stress. Transcriptomic analysis revealed host gene expression changes associated with membrane remodeling, ion transport, and metabolic buffering, suggesting that CBOs modulate the host in protective and adaptive ways. Together, these findings establish CBOs as a novel hybrid material platform for intracellular engineering while addressing key limitations of current synthetic organelle systems. CBOs open new possibilities for cellular modulation in therapeutic and diagnostic applications.

Related

  1. Arming the living drugs: nanoengineered bacteria for precision tumor theranostics
    Youyi Yu, Weitao Yang, Bingbo Zhang
    Journal of NanobiotechnologyPeer-reviewedCC BY-NC-ND 4.0Full textSystems & synthetic biologyPMC
  2. A transporter essential for apical secretory organelles homeostasis in Toxoplasma gondii
    A. Bonavoglia, R. Humann, O. Vadas +5
    bioRxivPreprintAll rights reservedFull textMicrobiologybioRxiv
  3. Calcium signaling in plant cell organelles delimited by a double membrane
    Tou-Cheu Xiong, Stéphane Bourque, David Lecourieux +6
    Biochimica et Biophysica Acta - Molecular Cell ResearchPeer-reviewedLicence not statedFull text64 citedPlant biologyHAL
  4. STING activation drives pericentrosomal positioning of acidic organelles via the VAIL-LRRK2-Rab35 pathway
    S. Suenaga, M. Sakurai, T. Iwatsubo +1
    bioRxivPreprintCC BYFull textCell biologybioRxiv
  5. A bacterial endosymbiont with a highly reduced genome forms extensive membrane contact sites with host organelles
    D. J. Leprich, J. Aaron, E. Hughes +3
    bioRxivPreprintCC BYFull textMicrobiologybioRxiv
BibTeX
@article{baghdasaryan2026cyborg,
  title = {{Cyborg bacteria as semi-living organelles for the augmentation of mammalian cells}},
  author = {Ofelya Baghdasaryan and Jared Lee-Kin and Russell C. Hovey and Cheemeng Tan},
  journal = {Bioactive Materials},
  year = {2026},
  month = nov,
  doi = {10.1016/j.bioactmat.2026.10.005},
  url = {https://doi.org/10.1016/j.bioactmat.2026.10.005},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Cyborg bacteria as semi-living organelles for the augmentation of mammalian cells
AU  - Ofelya Baghdasaryan
AU  - Jared Lee-Kin
AU  - Russell C. Hovey
AU  - Cheemeng Tan
PY  - 2026
DA  - 2026/11/16
JO  - Bioactive Materials
DO  - 10.1016/j.bioactmat.2026.10.005
UR  - https://doi.org/10.1016/j.bioactmat.2026.10.005
AB  - Synthetic organelles are engineered to replicate the compartmentalization and dynamic functionality of natural organelles, offering the potential to reprogram or rescue cellular functions. Existing approaches, such as protein cages, biomolecular condensates, and other artificial compartments, have shown promise but remain limited by their capacity to perform multifunctional tasks. To overcome these challenges, we introduce Cyborg Bacterial Organelles (CBOs), which are non-replicating, metabolically active bacteria engineered to function as living synthetic organelles within mammalian cells. Unlike synthetic systems or replicating endosymbionts, CBOs integrate the biological complexity of living organisms with the stability and tunability of engineered materials. CBOs are generated by permeating bacteria with poly(ethylene glycol) diacrylate (PEG) based monomers followed by intracellular UV induced hydrogel crosslinking, producing a structurally reinforced, non-replicative chassis capable of sustained activity inside host cells. Here, we show that CBOs remained detectable inside mammalian cells with substantially reduced morphological disruption compared with wild-type bacteria. Furthermore, we show that CBOs can perform complex functions intracellularly, including responses to extracellular chemical stimuli via synthetic gene circuits and execution of enzymatic reactions such as prodrug conversion into a therapeutic drug. Notably, we also show that CBOs protect host cells from chemically induced mitochondrial stress. Transcriptomic analysis revealed host gene expression changes associated with membrane remodeling, ion transport, and metabolic buffering, suggesting that CBOs modulate the host in protective and adaptive ways. Together, these findings establish CBOs as a novel hybrid material platform for intracellular engineering while addressing key limitations of current synthetic organelle systems. CBOs open new possibilities for cellular modulation in therapeutic and diagnostic applications.
SN  - 2452-199X
ER  -